Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Performance in Initiating Research, January 2015 Research Ethics Committee Reference Number Name of Trial Date of Receipt of Valid Research Application Date of NHS Permission First Patient Recruited? 12/SS/0138 RESTART or STOP Antithrombotics Randomised Trial: RESTART 26/03/2014 22/04/2014 No 11/WM/0164 AntiEpileptic drug Monitoring in PREgnancy: An evaluation of effectiveness, costeffectiveness and acceptability of dose monitoring strategies: EMPIRE 15/05/2014 20/05/2014 Yes 13/NE/0262 A Phase 3 randomised, double-blind, placebocontrolled, study of the efficacy and safety of 2 doses of Tofacitinib (CP690,550) or Adalimumab in Subjects with Active Psoriatic Arthritis 21/05/2014 21/05/2014 No Date of First Patient Recruited Duration Between VRA and NHS Permission (days) Duration Between NHS Permission and First Patient (days) Duration Between VRA and First Patient (days) 27 12/08/2014 5 0 84 89 Benchmark Met Reasons for not meeting Benchmark No No eligible patients seen. No No patients consented. No Sponsor delayed 'Green Light' date; then no eligible patients seen. 13/NW/0738 A pilot study to assess whether humidified oxygen is more effective than standard oxygen therapy in treating children with acute severe asthma: HUMOX 13/SC/0436 Early low dose steroids for adults admitted to hospital with influenza-like illness during a pandemic: a randomised placebo controlled trial: ASAP 13/LO/1115 13/NW/0184 UK Multicentre Open label Randomised Controlled Trial Of IV Iron Therapy In Incident Haemodialysis Patients: PIVOTAL The clinical and costeffectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations; a pragmatic, randomised, 21/05/2014 22/05/2014 No 1 0 No Sponsor delayed 'Green Light' date; then no eligible patients seen. No No patients seen. We can only recruit to study if there is a flu pandemic. 12/06/2014 12/06/2014 No 30/06/2014 02/07/2014 Yes 24/11/14 2 145 147 No No eligible patients seen. 29/07/2014 04/08/2014 Yes 02/09/2014 6 29 35 Yes N/A Benchmark met normal care controlled, clinical trial 13/WA/1084 A NCRI AML working group pilot under the auspices of the Cardiff experimental cancer medicine centre to establish the feasibility of combining the tyrosine kinase inhibitor, ponatinib with chemotherapy in patients with AML with a flt3 mutation 29/07/2014 07/08/2014 No 9 No No patients seen. 13/NS/0115 A multicentre RCT comparing laparoscopic supra-cervical hysterectomy with second generation ablation for the treatment of heavy menstrual bleeding: HEALTH 14/08/2014 20/08/2014 No 6 No No patients consented. 13/EM/0239 Remifentanil intravenous patient controlled analgesia (PCA) versus intramuscular pethidine for pain relief in labour: a No Staff availability issues and also no patients consented 20/08/2014 21/08/2014 No 1 randomised controlled trial 14/NW/1234 Pulse on the Finger – Is an iphone app accurate enough to measure heart rates in adult patients presenting to the emergency department compared to radial pulse palpation 13/NS/0143 SIMS Adjustable Anchored SingleIncision MiniSlings Versus Standard TensionFree MidUrethral Slings in the Surgical Management Of Female Stress Urinary Incontinence; A Pragmatic Multicentre Non–Inferiority RCT 11/08/2014 09/10/2014 21/08/2014 10/12/2014 Yes No 08/09/2014 10 18 28 Yes N/A Benchmark met No Study suspended by Sponsor - Sponsor advised currently unable to recruit and randomised any patients at any site. 14/WM/1078 A Randomised double-blind, placebocontrolled phase 2 study to assess the immune response follownig administration of Zoster Vaccine to subjects with RA receiving Tofacitinib (CP690,550) or placebo with background methotrexate treatment 26/11/2014 10/12/2014 No No Sponsor delays Sponsor delays in supplying IMP to site.